started · updated
Italy medical experts report advancements in cancer therapies and women's health
Medical experts in Italy are highlighting significant advancements and challenges across several health sectors. At the Intergruppo Melanoma Italiano (IMI) national congress in Bologna, specialists discussed the rising incidence of melanoma and the transformative impact of immunotherapy and genomic profiling, noting that over 50% of metastatic melanoma patients now survive 10 years post-diagnosis. Experts emphasized the need for digitalization and artificial intelligence to improve diagnostic accuracy and personalized prevention.
In hematology, AIFA has approved a new therapy using belantamab mafodotin to manage first-stage recurrence in multiple myeloma patients, aiming to improve life expectancy and quality of life. Additionally, the oncology department in Ariano Irpino has implemented an innovative protocol combining durvalumab with FLOT chemotherapy for stomach cancer treatment, following the international MATTERHORN study.
Regarding women's health, Bayer Italia reported findings from a survey indicating that while awareness of menopause is increasing, a significant portion of women still hide symptoms like hot flashes and insomnia. Experts warn that these symptoms can pose cardiovascular risks and impact daily productivity, urging women to consult doctors rather than enduring discomfort.
Entities
AIFA · Bayer Italia · Bologna · Daniela Massi · Intergruppo melanoma italiano · Mario Mandalà · Ospedale F. Miulli · Policlinico di Bari · Vincenzo De Giorgi
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 2 SOURCES] Melanoma causes approximately 2,500 deaths per year in Italy.
- [● 2 SOURCES] The five-year survival rate for melanoma in Italy exceeds 90%.
- [● 2 SOURCES] Artificial intelligence can serve as a specialized co-pilot to support pathologists in diagnosis.
- [● 2 SOURCES] More than 12,900 people are diagnosed with melanoma annually in Italy.
- [● 2 SOURCES] Over 221,000 patients in Italy are currently living with a melanoma diagnosis.